April 22, 2025 Dual Therapy Lowers Death Risk in Diabetes Study A large study found that combining GLP-1 receptor agonists with thiazolidinediones significantly reduced death and heart risks in patients with type 2 diabetes. Conexiant
April 23, 2025 AI Integration in Global Programs of CT Screening for Lung Cancer and Other Tobacco-Related Illnesses The ASCO Post
April 23, 2025 Final Results of LIBRETTO-001: Selpercatinib in RET Fusion–Positive NSCLC The ASCO Post
April 22, 2025 MRD and Adjuvant Osimertinib in Resected EGFR-Mutated Stage IB–IIIA NSCLC The ASCO Post
July 12, 2023 Changing How Immune Checkpoint Inhibitors Are Delivered Could Reduce Costs by 14%, Study Finds The ASCO Post